# MarketFlow Predictive Usefulness Acceptance Readiness Review Rerun Using Refined Evidence Status

## Branch And Scope

- Branch: `feature/predictive-usefulness-acceptance-readiness-review-rerun-refined-evidence-v1`.
- Base commit: `7fcb4fb8cd3644736e7c8baceece7c4b34dee7a8`.
- Commit: recorded by this document's implementing commit after validation.
- Scope: deterministic, offline acceptance-readiness review of the completed reassessment rerun. This review grants no predictive-usefulness acceptance, profitability acceptance, runtime migration, strategy, paper, broker, scoring, or recommendation authority.

## Review Artifact And Decision

- Artifact: `PREDICTIVE_USEFULNESS_ACCEPTANCE_READINESS_REVIEW_RERUN_USING_REFINED_EVIDENCE`.
- Schema: `predictive_usefulness_acceptance_readiness_review_rerun_using_refined_evidence_v1`.
- Status: `PREDICTIVE_USEFULNESS_ACCEPTANCE_READINESS_REVIEW_RERUN_USING_REFINED_EVIDENCE_COMPLETED`.
- Decision: `PREDICTIVE_USEFULNESS_ACCEPTANCE_NOT_READY_USING_REFINED_EVIDENCE`.
- Reason: `REFINED_EVIDENCE_WEAK_OR_MIXED_AND_INSUFFICIENT_BASELINE_OUTPERFORMANCE`.
- Review digest: `1b7e9d447290330cbecb70ec5897791d51d187886ab9a8145e6ecaf0f61c2991`.

## Bound Source Evidence

- Reassessment-rerun digest: `7520cd1c2f8d727ad7e94c0313c78e8bbb39bae410feeda539dd242ede28fcc0`.
- Refined-results-review digest: `539d06be9b20edee5ff883030e4fd1091fdaefb468fa595001178bf7ec0740da`.
- Refined-execution digest: `9cf962933620f066dfb105845428a262743f9f36dbc2850838321f23de10b5fd`.
- Refined-execution-approval digest: `5ad7b3b8df3156ab6b35b9490dcd4ae05bda3d1a7786212481b78d549103a8dd`.
- Research-registry approval digest: `5f0ce29bd06f1a0d5f1ce3dd8e31b8c8e52d616673f119326377538228d3d958`.
- Canonical-freeze / records digests: `02af746fa11fa292a84e000ff8ca19a0b4ab36937558f938e4ac04eef6be92fc` / `fbd7c1b17b42e5d4f82a9162b31b45fdfeef46f0e9ee7d29d74c926f0cf19044`.

## Registry-Approved Dataset Metadata And Universe

- Dataset/scope/status: `expanded_universe_canonical_dataset_v1` / `CANONICAL_DATASET_GENERATION_RESEARCH_ONLY` / `APPROVED_FOR_RESEARCH_REGISTRY_ONLY`.
- Profile/timeframe/range: `RTH_FULL_SESSION_1D` / `1d` / `2022-01-01` through `2025-12-31`.
- Label/data quality: `RESEARCH_ONLY_NON_ACTIONABLE` / `PASS_WITH_PRESERVED_SOURCE_LIMITATION`.
- Exact universe: `MSFT`, `NVDA`, `AMZN`, `GOOGL`, `META`, `TSLA`, `JPM`, `XOM`, `JNJ`, `WMT`, `CAT`, `LMT`.
- Total records: `11946`; META remains `913`, and each other ticker remains `1003`.

## Readiness Criteria And Findings

- `leakage_controls_pass_required`: `PASS`.
- `no_failed_controls_required`: `PASS`.
- `minimum_refined_evidence_review_completion_required`: `PASS`.
- `refined_oos_performance_minimum_required`: `FAIL_OR_NOT_MET`.
- `refined_signal_consistency_required`: `FAIL_OR_NOT_MET`.
- `refined_baseline_outperformance_required`: `FAIL_OR_NOT_MET`.
- `model_comparison_support_required`: `FAIL_OR_NOT_MET`.
- `calibration_stability_support_required`: `FAIL_OR_NOT_MET`.
- `operator_acceptance_boundary_required`: `PASS`.
- `profitability_separation_required`: `PASS`.
- `runtime_separation_required`: `PASS`.

The completed source review is sufficient to make a readiness decision, but weak or mixed signal, low-to-mixed OOS performance, insufficient or mixed baseline outperformance, research-only model comparison, and unaccepted calibration stability do not support acceptance.

## Per-Ticker Readiness Summary

- Twelve entries are present in exact universe order, each bound to the reassessment-rerun digest and its own deterministic readiness digest.
- MSFT, NVDA, AMZN, GOOGL, TSLA, JPM, XOM, JNJ, WMT, CAT, and LMT each preserve `1003` records.
- META preserves exactly `913` records and `PRESERVE_REDUCED_RECORD_COUNT_AND_INCLUDE_LIMITATION_FLAG_IN_READINESS_RERUN`.
- Every ticker is `NOT_READY_USING_REFINED_EVIDENCE`; predictive usefulness and profitability remain `not accepted`, and runtime/strategy/paper/broker remain `NOT_AUTHORIZED`.

## Future Improvement Chain And Gates

1. Refined Evidence Improvement Candidate, if desired.
2. Additional refined feature/label/model evidence planning, if desired.
3. Additional refined predictive evidence execution candidate, if new evidence is proposed.
4. Additional refined predictive evidence execution approval and execution, if separately approved.
5. Refined evidence results review.
6. Predictive usefulness reassessment review rerun.
7. Predictive usefulness acceptance readiness review rerun.
8. Predictive usefulness acceptance candidate, only if readiness passes.
9. Profitability review chain, if separately required.
10. Runtime migration chain, if ever separately authorized.

The eight future gates cover improvement planning, separately approved evidence execution and review, reassessment/readiness reruns, a conditional acceptance candidate, profitability review, and runtime migration. All five planned outputs remain `PLANNED_NOT_GENERATED` and `RESEARCH_ONLY_NON_ACTIONABLE`.

## Risk Controls And Authority Boundaries

- No acceptance is allowed while readiness is not met or without a positive future readiness decision.
- Weak/mixed refined signal, low/mixed OOS accuracy, model comparison, and calibration stability are not acceptance evidence by themselves.
- The frozen canonical dataset is not mutated and refined evidence is not rerun without a new approval.
- No provider request, live transport, acquisition, regeneration, recomputation, automatic stitching, scoring, recommendation, paper trading, or broker execution occurred.
- Predictive usefulness remains `not accepted`; the acceptance candidate and ceremony remain closed.
- Profitability remains `not accepted` and requires its own review chain.
- Runtime migration is unapproved/inactive; runtime and strategy use remain `NOT_AUTHORIZED`.

## Checklist Summary

- Checklist: `79 / 79` passed, `0` failed, and `0` blockers.
- The passed checklist means the not-ready decision and all closed authority boundaries are internally consistent. It does not mean predictive usefulness passed readiness.
- The artifact is ready only for refined-evidence improvement or additional-evidence planning.

## Next Task Recommendation

- `Refined Evidence Improvement Candidate v1`, if desired, or pause before any further improvement cycle.
